跳至主要内容
临床试验/NCT05831098
NCT05831098已完成不适用

Evaluation of the Sensitivity, Specificity, and Utility of the Reveal® TP (Syphilis) Antibody POCT to Diagnose Infectious Syphilis in Participants Attending the BCCDC's STI Clinic in Vancouver, BC

MedMira Laboratories Inc.1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2023年5月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
600
试验地点
1
主要终点
To determine the accuracy of Reveal TP (Syphilis) Antibody Test

研究概览

简要总结

This study is to test the Reveal® TP (Syphilis) antibody POCT (MedMira, Inc., Halifax, Nova Scotia) for its performance in an urban STI clinic in Vancouver, British Columbia and compare its performance in parallel with the usual testing method (the gold standard).

详细描述

This study is to test the Reveal® TP (Syphilis) antibody POCT (MedMira, Inc., Halifax, Nova Scotia) for its performance in an urban STI clinic in Vancouver, British Columbia and compare its performance in parallel with the usual testing method (the gold standard).

The healthcare professional will advise patients about the study, and with their permission refer them to research staff for recruitment. Should patients choose to participate in the study they will be asked to provide consent to have a few drops of blood sample obtained through a finger prick to be used in the POCT. POCT results will not be provided to participants and this will be explained in both the recruitment script and informed consent form. A sample of 5 to 10 ml venous whole blood will also be obtained for the conventional syphilis serology testing which is part of the routine for care of the four categories of patients (regardless of this research). This research will take approximately 15 to 30 minutes and will be on top of the regular care that patients will receive in the clinic. Upon completing the tests, participants will be asked to complete a brief feedback survey to assess patients' acceptability of syphilis POCT.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

盲法说明

The result of the Reveal TP (Syphilis) Antibody Test will not be revealed to the participant.

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients 19 years of age and above attending the BCCDC STI Clinic in Vancouver, British Columbia for routine sexual health care and requiring syphilis testing as part of this care are eligible for this study.
  • Additionally, for each participant category:
  • Group 1: No known (i.e. self-reported or laboratory documented history of syphilis) prior history of syphilis.
  • Group 2: No additional inclusion criteria
  • Group 3: Participants were named as a contact by a confirmed syphilis case within the last year, and have not yet received treatment
  • Group 4: No additional inclusion criteria
  • Those who had other STIs in the past or being suspected of having other STIs are not excluded as long as testing for syphilis is part of the care provided to them. Once it has been determined that the

排除标准

  • does not apply to a patient, the recruitment of the four categories of participants will be offered without other pre-selection criteria unless there may be other unforeseeable circumstances arising, such as shortage of clinic staff or large number of patients showing up.
  • Exclusion Criteria:
  • • Minors, and those who, at the discretion of the health care provider/research co-ordinator, appear intoxicated and/or with extreme distress, or confused, will be excluded from this research because they would not be able to provide informed consent to participate.
  • Additionally, for each participant category:
  • Group 1: Current symptoms that could be consistent with early syphilis.
  • Group 2: No additional exclusion criteria
  • Group 3: Current symptoms that could be consistent with early syphilis.
  • Group 4: Current symptoms that could be consistent with early syphilis.

研究组 & 干预措施

Experimental Diagnostic: Reveal TP (Syphilis) Antibody Test

Experimental

Participants are tested with investigational devices and conventional syphilis serology tests.

干预措施: Reveal TP (Syphilis) Antibody Test (Device)

结局指标

主要结局

To determine the accuracy of Reveal TP (Syphilis) Antibody Test

时间窗: 1 patient visit of approximately 30 minutes

For each enrolled subject, Reveal TP (Syphilis) Antibody Test will be used to test fingerstick whole blood from the patient. A venipuncture whole blood sample will also be drawn from the patient and will be tested using conventional serological testing methods to determine patient status.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验